Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  ErbB-2 inhibitor ARRY-380
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Phase 2 Study of Tucatinib vs Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: ONT-380-206, NCI-2016-00402, NCT02614794
ErbB-2 Inhibitor ARRY-380 and Trastuzumab in Treating Patients with HER2-Positive Metastatic Colon or Rectal Cancer
Status: Not yet active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: ACCRU-GI-1617, NCI-2017-01107, NCT03043313
Start Over